Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China Essex Bio-Technology Limited Jul 25, 2025 11:52 JST Read More
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million Everest Medicines Limited Jul 25, 2025 11:01 JST Read More
HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry HKTDC Jul 24, 2025 18:43 JST Read More
Launch of Beova(R) Tablets in Thailand for Overactive Bladder Eisai Jul 23, 2025 09:07 HKT/SGT Read More
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support Crown Bioscience Jul 23, 2025 09:00 HKT/SGT Read More
Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer's Association International Conference 2025 Eisai Jul 22, 2025 10:56 HKT/SGT Read More
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today China Medical System Holdings Ltd. Jul 16, 2025 16:00 JST Read More
Eisai Awarded "The 9th Bioindustry Award" for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab Eisai Jul 16, 2025 13:50 HKT/SGT Read More
Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection Fujitsu Ltd Jul 16, 2025 09:20 HKT/SGT Read More
"URECE" (Dotinurad) Launched in China as a treatment for Gout Eisai Jul 14, 2025 09:20 HKT/SGT Read More
Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment Eisai Jul 08, 2025 08:31 HKT/SGT Read More
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange China Medical System Holdings Ltd. Jun 25, 2025 19:00 JST Read More
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis Hua Medicine Jun 23, 2025 12:05 HKT/SGT Read More
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health CanSino Biologics Inc Jun 20, 2025 18:06 HKT/SGT Read More
NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment NEC Corporation Jun 18, 2025 12:40 HKT/SGT Read More
Jacobson Pharma Announces FY2025 Annual Results Jacobson Pharma Corporation Limited Jun 13, 2025 19:16 HKT/SGT Read More
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050 NEC Corporation Jun 02, 2025 16:56 HKT/SGT Read More
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan Eisai Jun 02, 2025 16:46 HKT/SGT Read More
JCB Collaborates with Noage International to Expand Advanced Medical Tourism Program in Japan for Affluent Indonesians JCB May 27, 2025 09:00 HKT/SGT Read More
Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China Everest Medicines Limited May 07, 2025 18:06 HKT/SGT Read More
